Role of metalloproteins in the clinical management of head and neck squamous cell carcinoma (Q28238012)

head and neck squamous cell carcinoma

Europe PubMed Central

title

Role of metalloproteins in the clinical management of head and neck squamous cell carcinoma (English)

0 references

main subject

1 reference

W Cooper Scurry

1

0 references

Brendan C Stack

series ordinal

2

0 references

language of work or name

English

0 references

publication date

December 2007

0 references

published in

Head & Neck

0 references

volume

29

0 references

issue

12

0 references

page(s)

1144-55

0 references

cites work

The mucosal invasion model: a novel in vitro model for evaluating the invasive behavior of mucocutaneous malignancies

1 reference

Metallopanstimulin as a marker for head and neck cancer

21 January 2018

1 reference

7 January 2021

The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck

1 reference

7 January 2021

Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck.

1 reference

7 January 2021

Matrix metalloproteinases

1 reference

7 January 2021

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

1 reference

7 January 2021

Changing views of the role of matrix metalloproteinases in metastasis

1 reference

7 January 2021

How matrix metalloproteinases regulate cell behavior

1 reference

7 January 2021

Cervical node metastasis from epidermoid carcinoma of the oral cavity and oropharynx. A critical assessment of current staging

1 reference

7 January 2021

Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer. A multivariate study of 492 cases

1 reference

7 January 2021

Lymph node prognostic factors in head and neck squamous cell carcinomas

1 reference

7 January 2021

Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor

1 reference

7 January 2021

Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma

1 reference

7 January 2021

Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells

1 reference

7 January 2021

Enhanced Production of Matrix Metalloproteinase-2 in Human Head and Neck Carcinomas is Correlated with Lymph Node Metastasis

1 reference

7 January 2021

Expression of type IV collagen and matrix metalloproteinase-2 (type IV collagenase) in relation to nodal status in laryngeal cancer

1 reference

7 January 2021

Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential

1 reference

7 January 2021

Activation of matrix metalloproteinase-2 in head and neck squamous cell carcinoma: studies of clinical samples and in vitro cell lines co-cultured with fibroblasts.

1 reference

7 January 2021

Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study

1 reference

7 January 2021

Expression of matrix metalloproteinase-3 in stage I and II squamous cell carcinoma of the oral cavity

1 reference

7 January 2021

Metaanalysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma

1 reference

7 January 2021

Role of membrane type 1-matrix metalloproteinase and gelatinase A in head and neck squamous cell carcinoma invasion in vitro

1 reference

7 January 2021

Expression of proteolytic enzymes in head and neck cancer-associated fibroblasts

1 reference

7 January 2021

Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion

1 reference

7 January 2021

Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma

1 reference

7 January 2021

Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx

1 reference

7 January 2021

Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis

1 reference

7 January 2021

Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis

1 reference

7 January 2021

Serum matrix metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic marker

1 reference

7 January 2021

Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein

1 reference

7 January 2021

Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma

1 reference

7 January 2021

Matrix metalloproteinase 3 polymorphism: a predictive factor of response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma.

1 reference

7 January 2021

Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma

1 reference

7 January 2021

Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization

1 reference

7 January 2021

Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours

1 reference

7 January 2021

Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma

1 reference

7 January 2021

Tissue and circulating immunoreactive protein for MMP-2 and TIMP-2 in head and neck squamous cell carcinoma--tissue immunoreactivity predicts aggressive clinical course

1 reference

7 January 2021

A new assay to screen for head and neck squamous cell carcinoma using the tumor marker metallopanstimulin

1 reference

7 January 2021

Identification of patients with head and neck cancer using serum protein profiles

1 reference

7 January 2021

Serum protein profiles to identify head and neck cancer

1 reference

7 January 2021

The Measurement of Observer Agreement for Categorical Data

1 reference

7 January 2021

Surveillance for recurrent head and neck cancer using positron emission tomography

1 reference

7 January 2021

Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imaging

1 reference

7 January 2021

Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study

1 reference

7 January 2021

Matrix metalloproteinase inhibitors as anticancer therapeutics.

1 reference

7 January 2021

Matrix metalloproteinase knockout studies and the potential use of matrix metalloproteinase inhibitors in the rheumatic diseases

1 reference

7 January 2021

COPD: current therapeutic interventions and future approaches

1 reference

7 January 2021

A synthetic matrix metalloproteinase inhibitor prevents squamous carcinoma cell proliferation by interfering with epidermal growth factor receptor autocrine loops

1 reference

7 January 2021

Inhibition of cervical lymph node metastasis by marimastat (BB-2516) in an orthotopic oral squamous cell carcinoma implantation model

1 reference

7 January 2021

Phase I trial of the matrix metalloproteinase inhibitor marimastat combined with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer

1 reference

7 January 2021

Marimastat in the treatment of patients with biochemically relapsed prostate cancer: a prospective randomized, double-blind, phase I/II trial

1 reference

7 January 2021

Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196

1 reference

7 January 2021

Exploiting molecular targets in pancreatic cancer

1 reference

7 January 2021

Matrix metalloproteinase inhibitors

1 reference

7 January 2021

Reduction of in vivo tumor growth by MMI-166, a selective matrix metalloproteinase inhibitor, through inhibition of tumor angiogenesis in squamous cell carcinoma cell lines of head and neck

1 reference

7 January 2021

Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients

1 reference

7 January 2021

Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis

1 reference

7 January 2021

Fusaric acid: a novel agent and mechanism to treat HNSCC.

1 reference

7 January 2021

Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of fusaric acid and paclitaxel or carboplatin

1 reference

7 January 2021

The effect of single agent oral fusaric acid (FA) on the growth of subcutaneously xenografted SCC-1 cells in a nude mouse model

1 reference

7 January 2021